Human NLGN4X knockout HeLa cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
- Sanger seq
Unknown
Sanger Sequencing - Human NLGN4X knockout HeLa cell lysate (AB263279)
Allele-1 : 1 bp deletion in exon 2
- Sanger seq
Unknown
Sanger Sequencing - Human NLGN4X knockout HeLa cell lysate (AB263279)
Allele-2 : Insertion of the selection cassette in exon 2
Complementary Products
Primary Antibodies
AB181251
Anti-Neuroligin 1 + Neuroligin 4 antibody [EPR13108]
RabMAb|Recombinant
![Western blot - Anti-Neuroligin 1 + Neuroligin 4 antibody [EPR13108] (AB181251)](https://content.abcam.com/products/images/neuroligin-1-neuroligin-4-antibody-epr13108-ab181251--western-blot-img126372.jpg)
- 0
- 0
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NLGN4X participates in the maintenance of synaptic function both in excitatory and inhibitory synapses. It forms part of a larger synaptic complex that includes neurexins and other proteins essential for synaptic adhesion and signal transduction. These complexes are necessary for precise neurotransmitter release and reception allowing neurons to reliably and efficiently communicate. The structural integrity provided by NLGN4X's presence in these complexes underlies normal synaptic operation and influences cognitive processes.
Pathways
Neuroligins belong to multiple neurological pathways emphasizing their role in synaptic organization and plasticity. NLGN4X engages with pathways like the synaptic vesicle cycle and postsynaptic density dynamics vital for modulating synaptic strength and plasticity. Through these pathways NLGN4X interacts closely with proteins such as neurexins facilitating synaptic organization and communication that are fundamental in neural network function.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com